Form 4 for HCWB HCW Biologics Inc.
Accepted 2022-06-02 00:00:00 ET · period of report 2022-05-31 · accession 0001209191-22-033517 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-06-02 | 2022-05-31 | HCWB | Jiao Jin-an | VP of Development | M - OptEx | $0.1482 | +14.6K | 45.1K | +48% | +$2,160 |
| DM | 2022-06-02 | 2022-05-31 | HCWB | Jiao Jin-an | VP of Development | M - OptEx | $0.00 | -14.6K | 18.0K | -45% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-05-31 | M | A | 12,856 | $0.14 | 43,427 | D | — | — | |
| 2 | Common | Common Stock | 2022-05-31 | M | A | 1,714 | $0.21 | 45,141 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2022-05-31 | M | D | 1,714 | $0.00 | 6,857 | D | $0.21 · — to 2030-12-22 | 1,714 Common Stock | (F2) 20% of the total shares subject to the stock option grant will vest on December 22, 2021; 20% of the total shares subject to the stock option grant will vest on December 22, 2022; 25% of the total shares subject to the stock option grant will vest on December 22, 2023; and 35% of the total shares subject to the stock option grant will vest on December 22, 2024. |
| 4 | Derivative | Stock Option (Right to Buy) | 2022-05-31 | M | D | 12,856 | $0.00 | 18,001 | D | $0.14 · — to 2029-05-29 | 12,856 Common Stock | (F1) These option shares were part of a stock option grant covering 51,428 shares of common stock. 20% of the total shares subject to the stock option grant vested on May 30, 2020; 20% of the total shares subject to the stock option grant vested on May 30, 2021; 25% of the total shares subject to the stock option grant will vest on May 30, 2022; and 35% of the total shares subject to the stock option grant will vest on May 30, 2023. |